Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Adient Reiterates FY24 Sales Outlook Of $15.4B-$15.5B Vs. $15.59B Estimate; Forecasts Adj. EBITDA Of $985M In FY24

Author: Benzinga Newsdesk | February 07, 2024 07:58am

Posted In: ADNT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist